These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 10182705)

  • 41. License terms for medical use licenses--NRC. Final rule.
    Fed Regist; 1998 Jun; 63(111):31604-7. PubMed ID: 10180132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Skin protectant drug products for over-the-counter human use; astringent drug products; final monograph; direct final rule. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(114):35290-3. PubMed ID: 12807133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Foreign establishment registration and listing. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Nov; 66(228):59138-61. PubMed ID: 11776289
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quality mammography standards; correction--FDA. Final rule; correction.
    Fed Regist; 1997 Nov; 62(217):60614-32. PubMed ID: 10177320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. General administrative rulings and decisions; amendment to the examination and investigation sample requirements; companion document to direct final rule--FDA. Proposed rule.
    Fed Regist; 1998 Sep; 63(186):51322-4. PubMed ID: 10185811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Guidance for Industry: For the Submission of Chemistry, Manufacturing and Controls and Establishment Description Information for Human Blood and Blood Components Intended for Transfusion or for Further Manufacture and for the Completion of the Form FDA 356h, 'Application to Market a New Drug, Biologic or an Antibiotic Drug for Human Use;'" availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 May; 64(89):25049-50. PubMed ID: 10558535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 May; 67(90):31123-5. PubMed ID: 12001971
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiology devices; classifications for five medical image management devices; correction--FDA. Final rule; correction.
    Fed Regist; 1998 Aug; 63(163):44998. PubMed ID: 10182691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supplemental applications proposing labeling changes for approved drugs, biologics, and medical devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Aug; 73(164):49603-10. PubMed ID: 18958946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Child-resistant packaging for certain over-the-counter drug products. Final rule.
    Consumer Product Safety Commission
    Fed Regist; 2001 Aug; 66(149):40111-6. PubMed ID: 11732555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical devices; designation of special control for eight surgical suture devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(106):32983-5. PubMed ID: 12784826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(216):66636. PubMed ID: 11503697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Draft guidance for industry on developing medical imaging drugs and biologics; availability--FDA. Availability of guidance.
    Fed Regist; 1998 Oct; 63(198):55067-9. PubMed ID: 10185833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revisions to the requirements applicable to blood, blood components, and source plasma. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Aug; 64(160):45366-74. PubMed ID: 10558597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Revision of the requirements for live vaccine processing. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Oct; 72(201):59000-3. PubMed ID: 17966559
    [TBL] [Abstract][Full Text] [Related]  

  • 56. List of drug products that have been withdrawn or removed from the market for reasons of safety or effectiveness. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Mar; 64(44):10944-7. PubMed ID: 10557618
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Food and Drug Administration regulations and licensure.
    Barker LF
    Fed Proc; 1975 May; 34(6):1522-4. PubMed ID: 1126452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Marketing health care products on the Internet: a proposal for updated federal regulations.
    Green K
    Am J Law Med; 1998; 24(2-3):365-86. PubMed ID: 9702278
    [No Abstract]   [Full Text] [Related]  

  • 59. Quality mammography standards. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Direct final rule.
    Fed Regist; 1999 Jun; 64(116):32404-7. PubMed ID: 10558582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical use of byproduct material--authorized user clarification. Direct final rule.
    Nuclear Regulatory Commission
    Fed Regist; 2009 Jul; 74(133):33901-6. PubMed ID: 19634251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.